MANKIND PHARMA
Back to All Ratios
|
MANKIND PHARMA Last 5 Year Earnings Per Share History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 32.00 | 35.78 | 31.59 | 25.72 | 14.44 |
What is the latest Earnings Per Share ratio of MANKIND PHARMA ?
Year | Earnings Per Share |
---|---|
Mar2023 | 32.00 |
Mar2022 | 35.78 |
Mar2021 | 31.59 |
Mar2020 | 25.72 |
Mar2019 | 14.44 |
How is Earnings Per Share of MANKIND PHARMA Trending?
Years | Earnings Per Share | % Change | |
---|---|---|---|
Mar2023 | 32 | -10.56 | |
Mar2022 | 35.78 | 13.26 | |
Mar2021 | 31.59 | 22.82 | |
Mar2020 | 25.72 | 78.12 | |
Mar2019 | 14.44 | - |
Other Financial Ratios of MANKIND PHARMA
Operational & Financial Ratios CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Earnings Per Share ratio of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹89,660.3 Cr | -2% | -5.1% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,400.0 Cr | -1.5% | -5.8% | 55.3% | Stock Analytics | |
CIPLA | ₹108,147.0 Cr | -5.9% | -8.4% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹100,664.0 Cr | -4.3% | -0.1% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,917.8 Cr | -3.7% | -1.8% | 84.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,703.0 Cr | -6.1% | -4.1% | 19.8% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -2% |
-5.1% |
|
SENSEX | -1.6% |
-2.1% |
19% |
You may also like the below Video Courses